Association of low serum magnesium with diabetes and hypertension: findings from Qatar Biobank Study.
|Author||Badi Abou-Samra, Abdul|
|Publication Name||Diabetes Research and Clinical Practice||en_US|
|Citation||Z. Shi, A. Badi Abou-Samra, Association of low serum magnesium with diabetes andhypertension: findings from Qatar Biobank Study, Diabetes Research and Clinical Practice (2019)|
|Abstract||We aimed to examine the association between serum magnesium and diabetes and hypertension among Qatari adults. In the cross-sectional study, we used data from 9693 Qatari participants) aged 20 years and above attending the Qatar Biobank (QBB) Study. Blood samples were analyzed in a central lab. Habitual food consumption was assessed by a food frequency questionnaire. Reduced rank regression was used to construct magnesium related dietary pattern (MRDP) using serum magnesium as a response variable. Diabetes was defined by blood glucose, HbA1c or known diabetes. Prediabetes was defined as HbA1c between 5.7% and 6.4%. Subclinical magnesium deficiency was defined as serum magnesium <0.85 mmol/L. The prevalence of diabetes, prediabetes and subclinical magnesium deficiency was 18.9%, 11.5% and 59.5%, respectively. Across the quartiles of serum magnesium from high to low, the prevalence ratios (PR 95%CI) for diabetes were 1.00, 1.35, 1.88, and 2.70 (95%CI 2.38-3.05), respectively (p for trend <0.001). The presence of hypertension significantly increased the probability of diabetes along a wide range of low serum magnesium. A low intake of MRDP was also positively associated with diabetes and high HbA1c. Subclinical magnesium deficiency is common in Qatar and associates with diabetes, prediabetes and hypertension in Qatari adults.|
|Title||Association of low serum magnesium with diabetes and hypertension: findings from Qatar Biobank Study.|
Check access options
Files in this item
There are no files associated with this item.
This item appears in the following Collection(s)
Human Nutrition [81 items ]